Celularity R&D Spending Growth & History (CELU)

Celularity's r&d spending was $15.0M for fiscal 2025.

View full Celularity company overview

Celularity annual r&d spending history

Celularity annual r&d spending

Fiscal yearPeriod endedR&D spendingChangeGrowth
20252025-12-31$15.0M−$2.4M−13.58%
20242024-12-31$17.4M−$13.1M−42.93%
20232023-12-31$30.5M−$47.9M−61.12%
20222022-12-31$78.4M−$10.0M−11.31%
20212021-12-31$88.4M$35.6M+67.63%
20202020-12-31$52.7M

Celularity r&d spending trends

Over the last five fiscal years, Celularity's r&d spending decreased from $52.7M to $15.0M, a change of −$37.7M. The latest reported quarter, Q4 2025, shows $3.3M.

About the metric

What research and development spending means

Research and development (R&D) spending covers the costs of creating and improving products, services, software, technologies, and processes. Higher R&D spending may support future innovation, but the amount alone does not show whether those investments will generate returns.

Calculation and source

SEC-reported R&D expense

TickerStat standardizes research and development expense reported in company SEC filings, including the software-specific US-GAAP R&D concept when it is the filer’s primary R&D expense line. It is historical company-reported spending, not an estimate or forecast. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Celularity source filings ↗

Community posts

It’s quiet here.

No posts about CELU yet. Start the conversation.

Write the first post